Saratov JOURNAL of Medical and Scientific Research

Treatment of thoracic spine spondylodiscitis in a patient who underwent COVID-19 (clinical case)

Year: 2021, volume 17 Issue: №4 Pages: 724-727
Heading: neurosurgery Article type: Case report
Authors: Chekhonatskiy V.A., Dreval O.N., Kuznetsov A.M., Mykhina O.V., Chapandze G.N., Magomedov H.A., Gorozhanin A.M., Sidorenko V.V.
Organization: Clinical Hospital n. a. S. P. Botkin
Summary:

Purpose: to demonstrate successful experience in the treatment of spondylodiscitis caused by Burkholderia cenocepacia in a patient who underwent COVID-19, to show minimalism of surgical trauma and low risk of postoperative complications. When analyzing the modern literature, there was not a single described case of spinal column spondylodiscitis, the causative agent of which was Burkholderia cenocepacia. Surgical treatment in the volume of percutaneous biopsy of Th5-Th6 vertebrae with microflora in combination with competently selected antibacterial therapy allowed to achieve early activation of the patient, reduce the time of medical and social rehabilitation, prevent the development of gross compression of neural structures.

Bibliography:
1. Guerado E, Cervan AM. Surgical treatment of spondylo-discitis. An update. Int Orthop 2012; (36): 413-20.
2. Vihnevskii AA, Babak SV. Nonspecific osteomyelitis of the spine caused by methicillin-resistant staphylococcus: rational antibiotic therapy. Difficult Patient 2014; (3): 39-44.
3. Fantoni М, Trecarichi ЕМ, Rossi В, et al. Epidemiological and clinical features of pyogenic spondylodiscitis. Eur Rev Med Pharmacol Sci 2012; 16 (2): 2-7.
4. Colmenero JD, Jimenez-Mejias ME, Reguera JM, et al. Tuberculous vertebral osteomyelitis in the new millennium: still a diagnostic and therapeutic challenge. Eur J Clin Microbiol Infect Dis 2004; (23): 477-83.
5. Раткин И. К., Матулевич А. В., Круглое И.А. и др. Опыт лечения больных с туберкулезом позвоночника. Сибирский научный медицинский журнал 2017; (2): 42-9.
6. Soares do Brito J, Tirado A, Fernandes P. Surgical treated spondylodiscitis epidemiological study. Acta Med Port 2016; 29 (5): 319-25.
7. Романов Б. К. Коронавирусная инфекция COVID-2019. Безопасность и риск фармакотерапии 2020; 8 (1): 3-8.
8. Dalakas МО Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications. Acta Myol 2020; 39 (4): 289-301.
9. Talamonti G, Colistra D, Crisa F. Spinal epidural abscess in COVID-19 patients. J Neurol 2021; 268 (7): 2320-6.
10. Tavares M, Kozak M, Balola A, et al. Burkholderia cepa-cia complex bacteria: A feared contamination risk in water-based pharmaceutical products. Clin Microbiol Rev 2020; 33 (3): 00139-19.

AttachmentSize
2021_04_724-727.pdf593.83 KB

No votes yet